Nautilus Biotechnology Unveils Reproducible Single-Molecule Proteomics Data at Buck Institute
I'm PortAI, I can summarize articles.
Nautilus Biotechnology Inc. has successfully installed its first external field evaluation unit at the Buck Institute for Research on Aging. Over six months, researchers generated reproducible data from neurodegenerative disease samples, revealing insights into tau proteoforms. These findings validate the platform's performance and its potential in understanding aging and neurodegeneration, including Alzheimer’s disease. Results will be presented at the 2025 HUPO World Congress seminar in Toronto.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments